162 results on '"Toroptsova N"'
Search Results
52. Osteoporosis and sarcopenia in women with rheumatoid arthritis
53. DIAGNOSIS FOR RISK FOR FALLS AND THEIR PREVENTION: DRAFT CLINICAL GUIDELINES BY THE ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA AND THE RUSSIAN OSTEOPOROSIS ASSOCIATION
54. Bone mineral density in women of reproductive age with rheumatic diseases
55. To help practitioner: monitoring treatment of osteoporosis in study of bone mineral density on different axial densitometers
56. Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
57. Bone status in young women with rheumatic diseases
58. OSTEOPOROSIS TREATMENT ADHERENCE: RESULTS FROM A RETROSPECTIVE COHORT STUDY
59. Musculoskeletal system pathology: focus on sarcopenia and osteosarcopenia
60. Possibilities of using a FRAX® risk calculator for 10-year probability of fractures assessment in patients with rheumatoid arthritis
61. Bone mineral density status and the need for anti-osteoporotic therapy in postmenopausal women with systemic scleroderma
62. Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
63. Bone mineral density in patients with systemic scleroderma
64. European multicentre pilot survey to assess vitamin D and clinical status in rheumatoid arthritis patients
65. Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
66. Risk factors for osteoporosis in men aged 40 years or older: the results of the program «Osteoscreening-Russia»
67. THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
68. THE RISK OF OSTEOPOROTIC FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF THE PROGRAM «OSTEOSCREENING RUSSIA»
69. THU0135 Using frax® and peripheral bone mineral density for identifying potential candidates for osteoporosis therapy among rheumatoid arthritis patients
70. AB0330 Osteoporosis, sarcopenia and osteosarcopenia in women with rheumatoid arthritis
71. AB0790 Frequency of osteoporosis in postmenopausal women with systemic sclerosis
72. Treatment of osteoporosis in patients who had low-energy fractures: challenges of diagnosis and commitment to pathogenetic treatment
73. REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
74. OSTEOPOROSIS IN RUSSIAN FEDERATION: EPIDEMIOLOGY, SOCIO-MEDICAL AND ECONOMICAL ASPECTS (REVIEW)
75. Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
76. FRI0567 Differences in adcherence to osteoporosis medications in patients with rheumatic diseases: a 3-year retrospective cohort study
77. THU0116 European multicentre pilot survey to assess vitamin d and clinical status in rheumatoid arthritis patients
78. THE RISK OF FALLS IN PATIENTS WITH RHEUMATOID ARTHRITIS
79. STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
80. SYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEM
81. THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
82. ASSESSMENT OF 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES WITH THE RUSSIAN MODEL OF FRAX® IN A POPULATION-BASED SAMPLE 5 REGIONS OF RUSSIA
83. DIAGNOSTIC POSSIBILITIES OF THE VARIOUS METHODS FOR THE IDENTIFICATION OF HIGH FRACTURE RISK POPULATIONS (FRAX®, DENSITOMETRY)
84. SUMMARY OF CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS OF THE RUSSIAN ASSOCIATION OF ENDOCRINOLOGISTS
85. PERIFERIChESKAYa RENTGENOVSKAYa DENSITOMETRIYa KAK PREDIKTOR OSTEOPOROZA OSEVOGO SKELETA U ZhENShchIN V POSTMENOPAUZE, PERENESShIKh NIZKOENERGETIChESKIE PERELOMY
86. ZATRATY NA LEChENIE BOL'NYKh S OSLOZhNENNYM OSTEOPOROZOM V TEChENIE ODNOGO GODA POSLE PERELOMA
87. PADENIYa U BOL'NYKh REVMATOIDNYM ARTRITOM: REZUL'TATY PROSPEKTIVNOGO NABLYuDENIYa
88. PROGNOZIROVANIE OSTEOPOROTIChESKIKh PERELOMOV U ZhENShchIN V POSTMENOPAUZE S ISPOL'ZOVANIEM ALGORITMA FRAX® I DENSITOMETRIChESKOGO OBSLEDOVANIYa
89. VOZMOZhNOST' ISPOL'ZOVANIYa FLYuOROGRAFOV DLYa SKRININGA NASELENIYa NA OSTEOPOROZ
90. DINAMIKA KAChESTVA ZhIZNI PO POKAZATELYaM EQ-5D, VASh I TTO U PATsIENTOV, PERENESShIKh OSTEOPOROTIChESKIY PERELOM
91. PERELOMY U ZhENShchIN V POSTMENOPAUZE S RAZLIChNYMI POKAZATELYaMI FRAX®
92. SYSTEMIC SCLEROSIS AND OSTEOPOROSIS
93. ASSESSMENT OF FRACTURES RISK USING THE FRAX® TOOL (A TEN-YEAR RETROSPECTIVE STUDY)
94. Search for genetic markers determining the efficiency of therapy with bisphosphonates in Russian women with postmenopausal osteoporosis: A pilot study
95. Bone mineral density in patients with scleroderma systematica
96. FARNESYL DIPHOSPHATE SYNTHASE (FDRS) AND GERANYLGERANYL DIPHOSPHATE SYNTHASE (GGSP1) GENE POLYMORPHISMS AND EFFICIENCY OF THERAPY WITH BISPHOSPHONATES IN RUSSIAN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY
97. OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
98. TREATMENT OF PATIENTS wITH OSTEOPOROSIS IN MODERN CLINICAL PRACTICE: ADHERENCE TO THERAPY
99. THE PREVENTION, DIAGNOSIS, AND TREATMENT OF VITAMIN D AND CALCIUM DEFICIENCIES IN THE ADULT POPULATION OF RUSSIA AND IN PATIENTS WITH OSTEOPOROSIS (ACCORDING TO THE MATERIALS OF PREPARED CLINICAL RECOMMENDATIONS)
100. FRI0092 Quality or Life in RA Patients: Risk of Falls and Fractures (3-Year Prospective Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.